中新网10月23日电 据科技部网站消息，欧盟第七研发框架计划(FP7)资助的，由苏格兰斯特拉斯克莱德大学(Strathclyde)和格拉斯格大学(Glasgow)教授领导的一个欧洲科研团队，利用从绿茶中提取的表没食子儿茶素没食子酸酯化合萃取物(Eplgallocatechin Gallate, EGCG)，直接作用于两种皮肤肿瘤，对两种皮肤癌的医治获得显著疗效。研究结果在最新一期的纳米医学杂志上发表。

Beijing on October 23, according to the ministry of science and technology news website,The European Union seventh research framework plan(FP7)funded,The suger lance special lasker rider university(Strathclyde)And grasse rutgers university(Glasgow)The leadership of the professor a European research team,Use extracted from green tea table gallnut catechins gallic acid esterification close extract(Eplgallocatechin Gallate, EGCG),Direct role in two kinds of skin cancer,Two kinds of skin cancer to the heal obtain remarkable curative effect.The results of the study in the latest issue of the nanometer journal of medicine.

　　绿茶萃取物已长期应用于癌症的治疗，但传统的静脉注射法往往效率不高，主要原因是肿瘤获取的萃取物不足。科研团队的研究人员，采用先进的定向投递系统技术(Targeted Delivery System)，可以让肿瘤有效地吸收萃取物，限制和降低肿瘤的生长速度。其工作机理是，将萃取物与携带铁原子的蛋白融合，可以更容易地被肿瘤依次吸收消化，从而促使肿瘤出现萎缩，甚至消失。

Green tea extract has long used in cancer treatment,But the traditional vein shots is often the efficiency is not high,The main reason is the lack of extract for tumor.Scientific research team of researchers,USES the advanced directional delivery system technology(Targeted Delivery System),Can let the tumor effectively absorb extract,Limit and reduce tumor growth speed.Its working mechanism is,Will extract and carrying iron atoms of fusion protein,Can more easily be tumor in digestive absorption,To facilitate tumor appears atrophy,Even disappear.

　　科研团队在实验室和临床上所进行的试验，已取得意想不到的成功。采取该方法医治的两种不同类型皮肤癌症患者，一个月后，接近三分之二的病患肿瘤得到有效控制。其中：30%的患者肿瘤完全消失，20%出现萎缩，另有10%得到稳定控制。进一步的研究证实，该医治方法对正常的人体组织细胞不产生任何副作用，即使对肿瘤继续生长的病患。

The scientific research team in the laboratory and clinical test,Already obtained unexpected success.Take the method of healing two different types of skin cancer patients,After a month,Nearly two-thirds of tumor patients get effective control.the:30% of the patients tumor completely disappeared,20% appears atrophy,Another 10% get stability control.Further studies confirm,This healing method to normal human tissue cells do not produce any side effects,Even for tumor patients continue to grow.

　　根据世界卫生组织(WHO)的统计报告，两种不同类型的皮肤癌症患者，非黑色素(Non-Melanoma)和黑色素(Melanoma)，在世界范围的持续地增长，每年新产生的非黑色素皮肤癌症患者达到200-300万之间，而黑色素皮肤癌症患者也达到了15万左右。科研团队研究开发出的治疗上述两种不同皮肤癌症的创新型技术，必将成为皮肤癌的杀手和患者的福音。

According to the world health organization(who)Statistical report,Two different types of skin cancer patients,Non melanin(Will Melanoma)And melanin(Melanoma),In the world of continuous growth,New Year from the non melanin skin cancer patients reached between 200-3 million,And the melanin of skin cancer patients to about 150000.Scientific research team developed the treatment of the above-mentioned two kinds of different skin cancer innovative technology,Skin will become the killer and the Gospel of the patients.